<SEC-DOCUMENT>0001628280-23-039562.txt : 20231120
<SEC-HEADER>0001628280-23-039562.hdr.sgml : 20231120
<ACCEPTANCE-DATETIME>20231120070529
ACCESSION NUMBER:		0001628280-23-039562
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20231120
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20231120
DATE AS OF CHANGE:		20231120

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			C4 Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001662579
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				475617627
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39567
		FILM NUMBER:		231420697

	BUSINESS ADDRESS:	
		STREET 1:		490 ARSENAL WAY
		STREET 2:		SUITE 120
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
		BUSINESS PHONE:		(617) 231-0700

	MAIL ADDRESS:	
		STREET 1:		490 ARSENAL WAY
		STREET 2:		SUITE 120
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cccc-20231120.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:d547ec5c-b039-43d8-876f-2227be322c45,g:47f3f9c8-e196-41d9-8c91-b2b6f5a789e4,d:3a951bb600504e9abdf356fa4669211e--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cccc-20231120</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-22">0001662579</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-23">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cccc-20231120.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001662579</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-20</xbrli:startDate><xbrli:endDate>2023-11-20</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i3a951bb600504e9abdf356fa4669211e_1"></div><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.1pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.855%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_________________________________________________________________</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_________________________________________________________________</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported):&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">November 20, 2023</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_________________________________________________________________</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">C4 THERAPEUTICS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Exact name of Registrant as Specified in Its Charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_________________________________________________________________</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.855%"><tr><td style="width:1.0%"></td><td style="width:32.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.182%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-39567</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">47-5617627</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or Other Jurisdiction</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">of Incorporation)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:133%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(IRS Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identification No.)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">490 Arsenal Way,</ix:nonNumeric>&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-8">Suite 120</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-9">Watertown,</ix:nonNumeric>&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-10">MA</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-11">02472</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:133%">(Address of Principal Executive Offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Zip Code)</span></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s Telephone Number, Including Area Code: (<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-12">617</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-13">231-0700</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_________________________________________________________________</span></div><div style="margin-top:12pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.855%"><tr><td style="width:1.0%"></td><td style="width:4.080%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.720%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:133%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-14">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:133%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-15">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:133%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-16">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:133%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-17">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.855%"><tr><td style="width:1.0%"></td><td style="width:38.617%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:133%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Symbol(s)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:133%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-18">Common Stock, $0.0001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-19">CCCC</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-20">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8201;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8201;240.12b-2 of this chapter).</span></div><div style="margin-top:12pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;</span><span style="color:#212529;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-21">o</ix:nonNumeric></span></div><div style="margin-top:12pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="color:#212529;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.855%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:2pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><span><br/></span></div></div></div><div id="i3a951bb600504e9abdf356fa4669211e_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.1pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div><div style="margin-top:6pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 16, 2023, the Board of Directors (the &#8220;</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) of C4 Therapeutics, Inc. (the &#8220;</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Owen P. Hughes, Jr. as a director of the Company. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time of his appointment, it was not determined which board committees Mr. Hughes would sit on.</span></div><div style="margin-top:6pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Hughes has been designated as a Class I director, to serve until the Company&#8217;s 2024 Annual Meeting of Stockholders, in accordance with the Company&#8217;s Second Amended and Restated By-Laws and to serve thereafter until his successor has been duly elected and qualified or until his earlier death, removal or resignation. </span></div><div style="margin-top:6pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with his appointment and in accordance with the Company&#8217;s compensation policy for non-employee directors, the Company granted to Mr. Hughes stock options to purchase up to 52,000 shares of the Company&#8217;s common stock under the Company&#8217;s 2020 Stock Option and Incentive Plan. One-third of this stock option award shall vest on the first anniversary of the date of grant, with the remainder vesting quarterly over the subsequent two years, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">however</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that all vesting of this award shall cease if Mr. Hughes resigns from the Board or otherwise ceases to serve as a director of the Company or otherwise maintain a service relationship with the Company prior to any such vesting date. In addition, in connection with his election, the Company is entering into an indemnification agreement with Mr. Hughes in the same form as used with the Company&#8217;s other directors.</span></div><div style="margin-top:6pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no arrangements or understandings between Mr. Hughes and any other persons pursuant to which he was selected as a director of the Company, and there are no transactions in which Mr. Hughes has an interest requiring disclosure under Item 404(a) of Regulation S-K.</span></div><div id="i3a951bb600504e9abdf356fa4669211e_99"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7.01 Regulation FD Disclosure.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 20, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company issued a press release announcing Mr. Hughes&#8217; appointment to the Board. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed &#8220;filed&#8221; for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exchange Act</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), or otherwise subject to the liabilities of that Section, nor shall it be deemed subject to the requirements of amended Item 10 of Regulation S-K, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing. The furnishing of this information hereby shall not be deemed an admission as to the materiality of any such information.</span></div><div id="i3a951bb600504e9abdf356fa4669211e_13"></div><div style="margin-top:12pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01 Financial Statements and Exhibits.</span></div><div style="margin-top:12pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibits</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The exhibits shall be deemed to be filed or furnished, depending on the relevant item requiring such exhibit, in accordance with the provisions of Item 601 of Regulation S-K (17 CFR 229.601) and Instruction B.2 to this form.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.855%"><tr><td style="width:1.0%"></td><td style="width:7.220%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.953%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:133%">Description</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">99.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="cccc-20231120xexx991.htm">Press release issued November 20, 2023</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">104</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><span><br/></span></div></div></div><div id="i3a951bb600504e9abdf356fa4669211e_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.1pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.855%"><tr><td style="width:1.0%"></td><td style="width:47.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.096%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">C4 Therapeutics, Inc.</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Date: </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">November 20, 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">By:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">/s/ Kendra R. Adams</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Kendra R. Adams</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Chief Financial Officer and Treasurer</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>cccc-20231120.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:d547ec5c-b039-43d8-876f-2227be322c45,g:47f3f9c8-e196-41d9-8c91-b2b6f5a789e4-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cccc="http://c4therapeutics.com/20231120" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://c4therapeutics.com/20231120">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cccc-20231120_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cccc-20231120_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPageDocument" roleURI="http://c4therapeutics.com/role/CoverPageDocument">
        <link:definition>0000001 - Document - Cover Page Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>3
<FILENAME>cccc-20231120_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:d547ec5c-b039-43d8-876f-2227be322c45,g:47f3f9c8-e196-41d9-8c91-b2b6f5a789e4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_37a912e2-e9b7-450b-9c0a-b023fbe87eed_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_b509b368-ee21-43d4-b6a5-03a0caba5821_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_ee14b179-a3ff-4885-8033-4b3e41d8b1a8_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_5211c008-1f50-4a3e-b878-e9e9b7765cf6_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_79e2e861-7e9f-4554-967f-57b0bca3034d_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_74c8e744-bcaa-41a5-95e3-a9888ec201c4_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_e23d2825-4b5a-4616-9cf2-a8938fca0df8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_e803431d-34f4-40ad-ae26-018115d4df4c_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_d346cfb5-b1a4-451e-830d-791e257494e5_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_730beacf-e2ae-497f-a9b6-a27aee3df826_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_bc7247ba-9acb-4715-8e8e-2a2a8244d056_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_7d6d63ca-a36e-4e6a-9517-e0adfdb4f469_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_f8fb32f6-d106-4c80-9ab1-60ec8b745f37_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_ab507ff4-00fc-456f-91a4-0e7ec4f51b1a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_7ee585a4-ab57-47e5-bd1b-6b39793cfabc_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_1d56cda1-7638-4766-bea9-72050615fd86_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_3e25064b-d516-439b-aab6-6f45e1bd7068_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_0ea086de-811a-4574-874b-8b2c28fe3e8b_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_ff3c9bb0-ce03-458f-8a18-95aea514dda8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_514ec3d4-6d99-49eb-8901-24e7cada3210_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_bee5e2e5-b907-479a-a63b-3c0408cdedf7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_eba8e761-27df-4246-9f6f-5cfb02185b3e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_aa0df1f7-d493-44bf-bade-c1185dc922a7_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>4
<FILENAME>cccc-20231120_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:d547ec5c-b039-43d8-876f-2227be322c45,g:47f3f9c8-e196-41d9-8c91-b2b6f5a789e4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://c4therapeutics.com/role/CoverPageDocument" xlink:type="simple" xlink:href="cccc-20231120.xsd#CoverPageDocument"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/CoverPageDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_bf07dc06-934c-4fca-af64-2ee6701aac8e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_24ec4610-3cc7-4799-ac93-b5d59837a922" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf07dc06-934c-4fca-af64-2ee6701aac8e" xlink:to="loc_dei_DocumentType_24ec4610-3cc7-4799-ac93-b5d59837a922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_0f6c2b12-f2e2-4868-96d8-43f65262e8d5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf07dc06-934c-4fca-af64-2ee6701aac8e" xlink:to="loc_dei_DocumentPeriodEndDate_0f6c2b12-f2e2-4868-96d8-43f65262e8d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_27f38617-ed1b-4875-ad30-e9060d3bd5f4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf07dc06-934c-4fca-af64-2ee6701aac8e" xlink:to="loc_dei_EntityRegistrantName_27f38617-ed1b-4875-ad30-e9060d3bd5f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_38b61f22-8ba1-4ea6-b8c1-64fec416fa83" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf07dc06-934c-4fca-af64-2ee6701aac8e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_38b61f22-8ba1-4ea6-b8c1-64fec416fa83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_7dd23d70-be99-4e6c-8809-32b8d86a780e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf07dc06-934c-4fca-af64-2ee6701aac8e" xlink:to="loc_dei_EntityFileNumber_7dd23d70-be99-4e6c-8809-32b8d86a780e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_5f80a251-1d74-4ce9-9c27-1161e5a6b060" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf07dc06-934c-4fca-af64-2ee6701aac8e" xlink:to="loc_dei_EntityTaxIdentificationNumber_5f80a251-1d74-4ce9-9c27-1161e5a6b060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_2b984f02-3954-4f52-bae5-2d10f7db8a99" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf07dc06-934c-4fca-af64-2ee6701aac8e" xlink:to="loc_dei_EntityAddressAddressLine1_2b984f02-3954-4f52-bae5-2d10f7db8a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_b0584b3b-10f6-40f4-a550-2fef15d34ae0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf07dc06-934c-4fca-af64-2ee6701aac8e" xlink:to="loc_dei_EntityAddressAddressLine2_b0584b3b-10f6-40f4-a550-2fef15d34ae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ed8c685d-0ad2-4e0b-879d-3848646ce3b7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf07dc06-934c-4fca-af64-2ee6701aac8e" xlink:to="loc_dei_EntityAddressCityOrTown_ed8c685d-0ad2-4e0b-879d-3848646ce3b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_c5fac6e8-5773-4846-a0ac-c84cd01d1eb2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf07dc06-934c-4fca-af64-2ee6701aac8e" xlink:to="loc_dei_EntityAddressStateOrProvince_c5fac6e8-5773-4846-a0ac-c84cd01d1eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_e4cf018d-274c-4fb0-b60d-0c52903c92cc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf07dc06-934c-4fca-af64-2ee6701aac8e" xlink:to="loc_dei_EntityAddressPostalZipCode_e4cf018d-274c-4fb0-b60d-0c52903c92cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_dc8ee8e8-201e-4bbe-b796-cf6bc2622a61" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf07dc06-934c-4fca-af64-2ee6701aac8e" xlink:to="loc_dei_CityAreaCode_dc8ee8e8-201e-4bbe-b796-cf6bc2622a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_304ea7e2-3518-4ede-9a15-7e5130af9dba" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf07dc06-934c-4fca-af64-2ee6701aac8e" xlink:to="loc_dei_LocalPhoneNumber_304ea7e2-3518-4ede-9a15-7e5130af9dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_24c3be5f-1afc-4e98-bad8-0d9e4f444fcf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf07dc06-934c-4fca-af64-2ee6701aac8e" xlink:to="loc_dei_WrittenCommunications_24c3be5f-1afc-4e98-bad8-0d9e4f444fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_a08f9f6f-5a68-4727-8f56-a6b1367b531d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf07dc06-934c-4fca-af64-2ee6701aac8e" xlink:to="loc_dei_SolicitingMaterial_a08f9f6f-5a68-4727-8f56-a6b1367b531d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_b3f7feb5-0c3d-49fd-9b6e-7c1fafe3b507" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf07dc06-934c-4fca-af64-2ee6701aac8e" xlink:to="loc_dei_PreCommencementTenderOffer_b3f7feb5-0c3d-49fd-9b6e-7c1fafe3b507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_db788c9f-d7df-4501-8e92-832aa01ccc9f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf07dc06-934c-4fca-af64-2ee6701aac8e" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_db788c9f-d7df-4501-8e92-832aa01ccc9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_dce7b15a-49cc-40eb-8cc0-d042ca133171" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf07dc06-934c-4fca-af64-2ee6701aac8e" xlink:to="loc_dei_Security12bTitle_dce7b15a-49cc-40eb-8cc0-d042ca133171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_26321b80-bb08-49b0-a741-5a6c960280b1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf07dc06-934c-4fca-af64-2ee6701aac8e" xlink:to="loc_dei_TradingSymbol_26321b80-bb08-49b0-a741-5a6c960280b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_f9f3bfbf-4463-4de6-85c9-a9dfbaac854a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf07dc06-934c-4fca-af64-2ee6701aac8e" xlink:to="loc_dei_SecurityExchangeName_f9f3bfbf-4463-4de6-85c9-a9dfbaac854a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_26d901a1-fbd5-43b3-8380-7d2b3de1325e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf07dc06-934c-4fca-af64-2ee6701aac8e" xlink:to="loc_dei_EntityEmergingGrowthCompany_26d901a1-fbd5-43b3-8380-7d2b3de1325e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_95a7d027-41a7-455e-9881-371b1b03745a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf07dc06-934c-4fca-af64-2ee6701aac8e" xlink:to="loc_dei_EntityCentralIndexKey_95a7d027-41a7-455e-9881-371b1b03745a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_a556997a-8c9c-4903-80cc-fad396e8e78b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf07dc06-934c-4fca-af64-2ee6701aac8e" xlink:to="loc_dei_AmendmentFlag_a556997a-8c9c-4903-80cc-fad396e8e78b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>cccc-20231120xexx991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i33022e49502c4d9ba3dabb1d30c62404_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div><div style="margin-top:6pt"><img alt="c4tlogo1.jpg" src="c4tlogo1.jpg" style="height:28px;margin-bottom:5pt;vertical-align:text-bottom;width:187px"></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">C4 Therapeutics Strengthens Board of Directors with Owen Hughes Appointment</font></div><div style="margin-top:12pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Owen Hughes, Accomplished Life Sciences Executive with Deep Experience Across Investing, Operations and Governance, Appointed as Independent Member of the Board of Directors</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WATERTOWN, Mass., November 20, 2023 (GLOBE NEWSWIRE) &#8211; C4 Therapeutics, Inc. (C4T) (Nasdaq&#58; CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science to develop a new generation of small-molecule medicines and transform how disease is treated, today announced the appointment of Owen Hughes to its board of directors. Mr. Hughes is an accomplished life sciences executive with nearly three decades of experience in investing, operations and corporate governance.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;We are thrilled to welcome Owen to the board of directors and leverage his experience across capital markets and pivotal business development opportunities,&#8221; said Bruce Downey, chairman of the board of directors of C4 Therapeutics. &#8220;His knowledge will help C4 Therapeutics strategically advance our portfolio of novel degrader medicines that have the potential to transform how disease is treated.&#8221;</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Mr. Hughes most recently served as co-founder and chief executive officer of Cullinan Oncology, where he led the development of the company&#8217;s portfolio of oncology assets through proof-of-concept. Under Mr. Hughes&#8217;s leadership, Cullinan raised over $400 million in capital through its initial public offering and advanced several assets into the clinic. Mr. Hughes also served as chief business officer of Intarcia Therapeutics, where he raised over $1.4 billion in capital and completed several portfolio deals totaling more than $1 billion. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Mr. Hughes started his career on Wall Street, initially in investment banking and equity research before transitioning to the buyside, where he managed public and private healthcare investments for Brookside Capital, a hedge fund under the Bain Capital umbrella, and Pyramis Advisors, a Fidelity Investments company.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Mr. Hughes currently serves as the executive chairman of Sail Bio and XOMA Corporation as well as the chairman of Ikena Oncology. He previously served on the boards of Radius Health (acquired by Gurnet Point Capital) and Translate Bio (acquired by Sanofi). Mr. Hughes earned a B.A. in history from Dartmouth College. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;It is a privilege to join C4T&#8217;s board and help advance targeted protein degradation in hopes it may offer patients and physicians a new therapeutic option,&#8221; said Mr. Hughes. &#8220;I look forward to working with the board of directors and management team to capitalize on the company&#8217;s scientific prowess to the benefit of patients and shareholders alike.&#8221; </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About C4 Therapeutics</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">C4 Therapeutics (C4T) (Nasdaq&#58; CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients&#8217; lives. C4T is leveraging its TORPEDO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> platform to efficiently design and optimize small-molecule medicines that harness the body&#8217;s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve patient outcomes. C4T is advancing multiple targeted oncology programs to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">clinic and expanding its research platform to deliver the next wave of medicines for difficult-to-treat diseases. For more information, please visit </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.c4therapeutics.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Forward-Looking Statements</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This press release contains &#8220;forward-looking statements&#8221; of C4 Therapeutics, Inc. within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may include, but may not be limited to, express or implied statements regarding our ability to develop potential therapies for patients&#59; the design and potential efficacy of our therapeutic approaches&#59; the potential timing, design and advancement of our preclinical studies and clinical trials, including the potential timing for and receipt of regulatory authorization related to clinical trials and other clinical development activities including clinical trial commencement&#59; and our ability to fund our future operations. Any forward-looking statements in this press release are based on management&#8217;s current expectations and beliefs of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to&#58; uncertainties related to the initiation, timing, advancement and conduct of preclinical and clinical studies and other development requirements for our product candidates&#59; the risk that any one or more of our product candidates will cost more to develop or may not be successfully developed and commercialized&#59; and the risk that sufficient capital to fund our future operations will be available to us on acceptable terms or at the times required. For a discussion of these and other risks and uncertainties, and other important factors, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section entitled &#8220;Risk Factors&#8221; in C4 Therapeutics&#8217; most recent Annual Report on Form 10-K and&#47;or Quarterly Report on Form 10-Q, as filed with the Securities and Exchange Commission. All information in this press release is as of the date of the release, and C4 Therapeutics undertakes no duty to update this information unless required by law.</font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Contacts&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Investors&#58;  </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Courtney Solberg </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Senior Manager, Investor Relations </font></div><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">CSolberg&#64;c4therapeutics.com</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Media&#58;  </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Loraine Spreen  </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Senior Director, Corporate Communications &#38; Patient Advocacy </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">LSpreen&#64;c4therapeutics.com</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>c4tlogo1.jpg
<TEXT>
begin 644 c4tlogo1.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !  :D# 2(  A$! Q$!_\0
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M?XM?#=/"OA^_L4O]'V26,,4ZLL6Q=FQ@,D J2OL<9Z5\=Q_LK_$JXUK^SO\
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MK-T#Q)IGBG3_ +=I-[%?VFXIYL1R-PQD?J*TJ "BBB@ HHHH **** "BBB@
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M_(@>(O\ KPF_] - 'D/[//C31? OP/BO];OH[*W-[,J[LEG;"G"J.2:W]/\
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M\40C6?$.K,;I7ODW"!=V5*J1P3@'/I@#%>J>)/A_X=\7:>UGJVCVEW!SMW1
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M#?VT+?*V1E947)(1L$8/0JPR<9K\N]6\-ZII.K-IEYI]S;:@K[#;21,)-Q.
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MT\!60ML%P@/ STR!D8/!!Q0!E?\ #.?BG_HK6O?^1O\ X_6-XN^ =WI^BO\
M\)+\8-1BTJ9EC<:AO\IV^\%(:?!/RY_"MF']H[6M!ACM/$W@35H-5507^RH3
M&PQ]X9'&3GCFL>_\(^./V@O$%@_B73W\+^#[1_-^QLQ$LW0]."21QD@!<GOP
M0#>^,&FVNC_LN_8;*]74K.VM+"*&\C&%F198@' R>".>IZUZ7\+_ /DFOA7_
M +!5K_Z*6N<^/OAV[UCX/:KI6D64EU<'[.L5O F3M6:,G 'H 3^%=3\.[.?3
M_ /ANUNHF@N8=.MXY8I!AD81J"#[@T >+^+KAM#_ &LO#UU=6N;:]M5@AFD
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M%%%>@>N%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!X5\+_^3C/B/_US3^:5[K7(^'_AKI_AWQQKOBB"YN9+S5U5989"OEIC
M'W<#/8=2:ZZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
##__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139728186979952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page Document<br></strong></div></th>
<th class="th"><div>Nov. 20, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 20,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">C4 THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-5617627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">490 Arsenal Way,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Watertown,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">617<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">231-0700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CCCC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001662579<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>cccc-20231120_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cccc-20231120.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001662579</identifier>
        </entity>
        <period>
            <startDate>2023-11-20</startDate>
            <endDate>2023-11-20</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-22">0001662579</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-23">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2023-11-20</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">C4 THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-39567</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">47-5617627</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">490 Arsenal Way,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-8">Suite 120</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-9">Watertown,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-10">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-11">02472</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-12">617</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-13">231-0700</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-14">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-18">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-19">CCCC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-20">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-21">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M#YZ>=9$:12]H=0.,K5PG?-S>\R0.X97M/ HN -,4 RE7!1^W\T\RA#&9KJ7
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MCMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " "N.'17VU\'[3D!   P @  #P
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M-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @
MKCAT5P=!36*!    L0   !               ( !     &1O8U!R;W!S+V%P
M<"YX;6Q02P$"% ,4    " "N.'173\&*0^X    K @  $0
M@ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " "N.'17F5R<(Q &
M  "<)P  $P              @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+
M 0(4 Q0    ( *XX=%=:9!]X800  "P1   8              " @0T(  !X
M;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " "N.'17GZ ;\+$"
M  #B#   #0              @ &D#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0
M   ( *XX=%>7BKL<P    !,"   +              "  8 /  !?<F5L<R\N
M<F5L<U!+ 0(4 Q0    ( *XX=%?;7P?M.0$  # "   /              "
M 6D0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "N.'17)!Z;HJT   #X
M 0  &@              @ '/$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E
M;'-02P$"% ,4    " "N.'1799!YDAD!  #/ P  $P              @ &T
L$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #^$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="cccc-20231120.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://c4therapeutics.com/role/CoverPageDocument</Role>
      <ShortName>Cover Page Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="cccc-20231120.htm">cccc-20231120.htm</File>
    <File>cccc-20231120.xsd</File>
    <File>cccc-20231120_lab.xml</File>
    <File>cccc-20231120_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "cccc-20231120.htm": {
   "nsprefix": "cccc",
   "nsuri": "http://c4therapeutics.com/20231120",
   "dts": {
    "inline": {
     "local": [
      "cccc-20231120.htm"
     ]
    },
    "schema": {
     "local": [
      "cccc-20231120.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cccc-20231120_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cccc-20231120_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://c4therapeutics.com/role/CoverPageDocument",
     "longName": "0000001 - Document - Cover Page Document",
     "shortName": "Cover Page Document",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cccc-20231120.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cccc-20231120.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://c4therapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://c4therapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://c4therapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://c4therapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://c4therapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://c4therapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://c4therapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://c4therapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://c4therapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://c4therapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://c4therapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://c4therapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://c4therapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://c4therapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://c4therapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://c4therapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://c4therapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://c4therapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://c4therapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://c4therapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://c4therapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://c4therapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://c4therapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001628280-23-039562-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-23-039562-xbrl.zip
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M"=760:O@&3 @H&N? CZOT#\9<JVB560COT:"IY\]7(^/-W=*Y/:T5%-(A&7
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MRQL)7XPP-A&N*K452J>"Z6B<MM7L2R)-"]D>] Q3PYHSTZ%X;8F^1]WZTN/
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MQ+O)N);[GZ>OUN\DR^_0/WWU?U!+ P04    " "N.'17@,0->=P&   @,P
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M=2!>J. DO'_I;L]BUJI(Q7V"\K 0F0QQ3%*@40L0 2W8P#10JBA*IWS>!/>
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M9])GUA4E+9H*D6M%>1"I1]Z(ICS9&H3</P$XG@#/ZV7=MHA\/ZC7:]!-[5_
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MTYGV_= 7:#/+OC5M;GT4?0CN_K-!M!UCQQ?A5X-?^%])_@-02P$"% ,4
M" "N.'17H-%I0  3  #$?@  $0              @ $     8V-C8RTR,#(S
M,3$R,"YH=&U02P$"% ,4    " "N.'17&+>W^GL"  "<!P  $0
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;,2YH=&U02P4&      4 !0!* 0  *S0

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
